Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture
Biotechnology Progress · 2023
DOI: 10.1002/btpr.3370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2023. Verfasst von Ranjeet Desai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Surface-Active Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST), Science and Engineering Research Board (SERB): Ramanujan Fellowship.
Abstract (Originalsprache)
Therapeutic monoclonal antibodies (mAbs) are biologics produced using mammalian cells and represent an important class of biotherapeutics. Aggregation in mAbs is a major challenge that can be mitigated by rigorous and reproducible upstream and downstream approaches. The impact of frequently used surfactants, like polysorbate 20, polysorbate 80, poloxamer 188, and 2‐hydroxypropyl‐beta‐cyclodextrin, on aggregation of mAbs during cell culture was investigated in this study. Their impact on cell proliferation, viability, and mAb titer was also investigated. Polysorbate 20 and polysorbate 80 at the concentration of 0.01 g/L and poloxamer 188 at the concentration of 5 g/L were found to be effective in reducing aggregate formation in cell culture medium, without affecting the cell growth or viability. Furthermore, their presence in culture media resulted in increased cell proliferation as compared to the control group. Addition of these surfactants at the specified concentrations increased monomer production while decreasing high molecular weight species in the medium. After mAbs were separated, using protein “A” chromatography, flasks with surfactant exhibited improved antibody stability, when analyzed by DLS. Thus, while producing aggregation‐prone mAbs via mammalian cell culture, these excipients may be employed as cell culture medium supplements to enhance the quality and yield of functional mAbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.
- Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Mumbai, India.
ORCID-Profile: Prajakta Dandekar
Förderung
- Council of Scientific and Industrial Research (CSIR)
- Department of Science and Technology (DST)
- Science and Engineering Research Board (SERB): Ramanujan Fellowship
- UGC
- DBT
- Ministry of Science and Technology: Ramalingaswami Fellowship
- Science and Engineering Research Board
- University Grants Commission of Bangladesh
Zitieren
APA
Desai, R., Jain, R., & Dandekar, P. (2023). Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture. Biotechnology Progress. https://doi.org/10.1002/btpr.3370
Vancouver
Desai R, Jain R, Dandekar P. Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture. Biotechnology Progress. 2023. doi:10.1002/btpr.3370
BibTeX
@article{Desai2023,
author = {Desai, Ranjeet and Jain, Ratnesh and Dandekar, Prajakta},
title = {Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture},
journal = {Biotechnology Progress},
year = {2023},
doi = {10.1002/btpr.3370}
}
EUVIMED